Risk Stratification of Pulmonary Embolism

Area of Science:

• Cardiology
• Pulmonary Medicine
• Medical Diagnostics

Background:

• Pulmonary embolism (PE) management involves diverse treatment options.
• Effective risk stratification is essential for identifying patients at high risk of mortality from PE.
• Current risk assessment tools aim to predict death from initial or recurrent PE events.

Purpose of the Study:

• To evaluate the effectiveness of risk stratification strategies in improving mortality rates for pulmonary embolism patients.
• To identify optimal methods for predicting mortality in PE patients.

Main Methods:

• Utilized all-cause death within 30 days post-diagnosis as a surrogate endpoint for PE-related mortality.
• Assessed the predictive value of clinical parameters, biomarkers, and radiologic evidence of right ventricular dysfunction and strain.

Main Results:

• Clinical parameters, biomarkers, and imaging findings indicative of right ventricular dysfunction and strain are predictive of 30-day mortality after PE diagnosis.
• No previous study has demonstrated that implementing a risk stratification strategy leads to improved mortality rates in PE patients.

Conclusions:

• While predictors of mortality in PE exist, their implementation into guided treatment strategies has not yet shown a mortality benefit.
• Further research with improved methodologies is needed to refine prognostic assessments and test novel management strategies for high-risk PE patients.